라메디텍

462510KOSDAQ의료용 기기 제조업

37.1 / 100

Reference Date: 2026-04-13

Financial Score6.0 / 40

News Sentiment18.1 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 9.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Lameditech is a company specializing in developing laser-based skincare and medical devices, as well as laser blood collection systems. Its key products include the Puracel series, CareBeam, Rayvet, and Handly, with laser skincare devices accounting for approximately 91% of total revenue in 2025.

Number of Employees

68people

Average Salary

54.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 26.524.0Point

PBR

5.04Industry Average 1.700.0Point

3.0x industry avg (risky)

ROE

-82.45Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

77.79Industry Average 10.950.0Point

7.1x industry avg (risky)

Trend 2024~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲9.3% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼22.6% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -75.5% (declining, 2yr)

Detailed News Sentiment

4 totalPositive 2Neutral 1Negative 0Average Sentiment Score 80

Positive
"바늘 없어도 채혈"…만성질환 관리 쉬워진다
라메디텍이 바늘 없는 레이저 채혈·혈당측정기를 통해 만성질환자들의 불편을 해소하고 삶의 질을 높이는 기술 혁신을 선보였습니다.
Neutral
“쿠팡도 우리 가격 못 따라 옵니다” 한국에서 가장 싼 쇼핑몰 만든.....
국내 기업 제품 위주로 단독 최저가로 승부하며 성장하고 있는 신생 커머스 기업 '조선몰'의 창업 스토리에 대한 내용입니다.
Positive
라메디텍–헤링스, 만성질환 모니터링 시스템 구축 MOU
라메디텍이 디지털 헬스케어 기업 헤링스와 AI 기반 만성질환 모니터링 통합관리 시스템 구축을 위한 업무협약(MOU)을 체결했습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (14%, downtrend)

Current 4,820Won52-week high 9,01052-week low 4,100

1-month return1.0Point

1m -9.06% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
Neutral정기주주총회결과2026-03-26
Neutral사업보고서 (2025.12)2026-03-17
Neutral감사보고서제출2026-03-16